IMS Health Holdings Inc. (NYSE:IMS) saw unusually-strong trading volume on Friday . Approximately 2,338,174 shares changed hands during mid-day trading, an increase of 59% from the previous session’s volume of 1,468,886 shares.The stock last traded at $27.68 and had previously closed at $26.78.

Several analysts have commented on the stock. Zacks Investment Research raised shares of IMS Health Holdings from a “hold” rating to a “buy” rating and set a $30.00 price target for the company in a research report on Monday, April 25th. Topeka Capital Markets increased their price target on shares of IMS Health Holdings from $29.00 to $30.00 and gave the company a “buy” rating in a research report on Wednesday, May 4th. Piper Jaffray Cos. reissued an “overweight” rating and set a $32.00 price target (up from $28.00) on shares of IMS Health Holdings in a research report on Thursday, March 24th. Finally, Wells Fargo & Co. lowered shares of IMS Health Holdings from an “outperform” rating to a “market perform” rating in a research report on Thursday, May 12th. Three investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. IMS Health Holdings currently has an average rating of “Buy” and an average target price of $31.22.

The company has a market capitalization of $9.13 billion and a PE ratio of 56.84. The company’s 50-day moving average is $25.50 and its 200 day moving average is $25.31.

IMS Health Holdings (NYSE:IMS) last issued its quarterly earnings data on Tuesday, May 3rd. The company reported $0.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.04. The company earned $774 million during the quarter, compared to analysts’ expectations of $749.34 million. The firm’s quarterly revenue was up 22.5% on a year-over-year basis. During the same quarter last year, the firm posted $0.39 earnings per share. On average, equities research analysts anticipate that IMS Health Holdings Inc. will post $1.60 earnings per share for the current fiscal year.

Other institutional investors have recently added to or reduced their stakes in the company. Korea Investment CORP purchased a new position in IMS Health Holdings during the fourth quarter valued at $1,077,000. Calamos Advisors LLC increased its position in IMS Health Holdings by 25.8% in the fourth quarter. Calamos Advisors LLC now owns 1,386,910 shares of the company’s stock valued at $35,325,000 after buying an additional 284,857 shares in the last quarter. Oxford Asset Management purchased a new position in IMS Health Holdings during the fourth quarter valued at $1,574,000. Stevens Capital Management LP increased its position in IMS Health Holdings by 44.5% in the fourth quarter. Stevens Capital Management LP now owns 82,102 shares of the company’s stock valued at $2,091,000 after buying an additional 25,277 shares in the last quarter. Finally, Great West Life Assurance Co. Can increased its position in IMS Health Holdings by 85.4% in the fourth quarter. Great West Life Assurance Co. Can now owns 76,933 shares of the company’s stock valued at $1,959,000 after buying an additional 35,431 shares in the last quarter.

IMS Health Holdings, Inc (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company’s data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.